胸外科医师学会、心血管麻醉医师学会与体外循环技术学会临床实践指南:体外循环期间的抗凝管理
Despite more than a half century of "safe" cardiopulmonary bypass (CPB), the evidence base surrounding the conduct of anticoagulation therapy for CPB has not been organized into a succinct guideline.…
要点
- 推荐涉及肝素剂量与监测、肝素禁忌与替代、抗凝逆转三个方面。
- 指南基于系统综述,证据级别按ACCF/AHA标准评估。
- 旨在减少体外循环抗凝实践的变异性并建立最佳实践。
核心结论
- 指南旨在填补体外循环抗凝治疗的证据空白,并建立基于现有证据的最佳实践。
主要发现
- 工作组基于纳入文献撰写推荐,每条推荐获得超过三分之二的同意。
关键数值与推荐
- 推荐涵盖三个领域:肝素剂量与监测(用于体外循环的启动和维持)、肝素禁忌与替代、心脏手术期间抗凝逆转。
- 证据质量按ACCF/AHA实践指南工作组建议的级别进行评估。
临床怎么用
- 临床医生可参考该指南规范体外循环期间的抗凝实践,包括肝素使用、监测、替代和逆转。
局限性
- 原文未明确报告指南的局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite more than a half century of "safe" cardiopulmonary bypass (CPB), the evidence base surrounding the conduct of anticoagulation therapy for CPB has not been organized into a succinct guideline. For this and other reasons, there is enormous practice variability relating to the use and dosing of heparin, monitoring heparin anticoagulation, reversal of anticoagulation, and the use of alternative anticoagulants. To address this and other gaps, The Society of Thoracic Surgeons, the Society of Cardiovascular Anesthesiologists, and the American Society of Extracorporeal Technology developed an Evidence Based Workgroup. This was a group of interdisciplinary professionals gathered to summarize the evidence and create practice recommendations for various aspects of CPB. To date, anticoagulation practices in CPB have not been standardized in accordance with the evidence base. This clinical practice guideline was written with the intent to fill the evidence gap and to establish best practices in anticoagulation therapy for CPB using the available evidence. To identify relevant evidence, a systematic review was outlined and literature searches were conducted in PubMed using standardized medical subject heading (MeSH) terms from the National Library of Medicine list of search terms. Search dates were inclusive of January 2000 to December 2015. The search yielded 833 abstracts, which were reviewed by two independent reviewers. Once accepted into the full manuscript review stage, two members of the writing group evaluated each of 286 full papers for inclusion eligibility into the guideline document. Ninety-six manuscripts were included in the final review. In addition, 17 manuscripts published before 2000 were included to provide method, context, or additional supporting evidence for the recommendations as these papers were considered sentinel publications. Members of the writing group wrote and developed recommendations based on review of the articles obtained and achieved more than two thirds agreement on each recommendation. The quality of information for a given recommendation allowed assessment of the level of evidence as recommended by the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Recommendations were written in the three following areas: (1) heparin dosing and monitoring for initiation and maintenance of CPB; (2) heparin contraindications and heparin alternatives; and (3) reversal of anticoagulation during cardiac operations. It is hoped that this guideline will serve as a resource and will stimulate investigators to conduct more research and to expand on the evidence base on the topic of anticoagulation therapy for CPB.
引用
- Shore-Lesserson L, Baker RA, Ferraris VA, et al. The Society of Thoracic Surgeons, The Society of Cardiovascular Anesthesiologists, and The American Society of ExtraCorporeal Technology: Clinical Practice Guidelines-Anticoagulation During Cardiopulmonary Bypass. Anesth Analg. 2018. PMID: 29346209. doi:10.1213/ANE.0000000000002613
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。